tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR

Compare Pharming Group (PHAR) vs. Competitors

Compare
197 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharming Group
$15.36
$1.11B
440.65
74.84%
2 Buy
0 Hold
0 Sell
Moderate Buy
Trevi Therapeutics
$13.47
$1.36B
-42.49
60.51%
7 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$11.16
$1.12B
-5.55
48.60%
10 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$298.31
$8.31B
-21.87
691.48%
13 Buy
1 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$8.89
$811.26M
-6.70
-42.91%
3 Buy
0 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.52
$635.54M
-2.57
75.12%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAR
Pharming Group
15.36
6.53
73.89%
TRVI
Trevi Therapeutics
10.61
4.21
65.78%
ORIC
Oric Pharmaceuticals
11.16
3.79
51.42%
PRAX
Praxis Precision Medicines
298.31
260.60
691.06%
SPRY
ARS Pharmaceuticals
8.17
-4.72
-36.62%
PRME
Prime Medicine, Inc.
3.52
1.49
73.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts